BlackRock Science Valuation

BSTZ Stock  USD 21.31  0.01  0.05%   
At this time, the firm appears to be fairly valued. BlackRock Science shows a prevailing Real Value of $22.15 per share. The current price of the firm is $21.31. Our model approximates the value of BlackRock Science from analyzing the firm fundamentals such as shares outstanding of 74.17 M, and Number Of Shares Shorted of 55.66 K as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting BlackRock Science's valuation include:
Price Book
0.9106
Price Sales
7.4333
Trailing PE
7.5035
Enterprise Value Revenue
7.2476
Fairly Valued
Today
21.31
Please note that BlackRock Science's price fluctuation is very steady at this time. Calculation of the real value of BlackRock Science is based on 3 months time horizon. Increasing BlackRock Science's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since BlackRock Science is currently traded on the exchange, buyers and sellers on that exchange determine the market value of BlackRock Stock. However, BlackRock Science's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  21.31 Real  22.15 Hype  21.37 Naive  21.39
The intrinsic value of BlackRock Science's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence BlackRock Science's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
22.15
Real Value
23.23
Upside
Estimating the potential upside or downside of BlackRock Science and helps investors to forecast how BlackRock stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of BlackRock Science more accurately as focusing exclusively on BlackRock Science's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
20.4421.1821.93
Details
Hype
Prediction
LowEstimatedHigh
20.2921.3722.45
Details
Potential
Annual Dividend
LowForecastedHigh
1.321.421.53
Details
Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use BlackRock Science's intrinsic value based on its ongoing forecasts of BlackRock Science's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against BlackRock Science's closest peers.

BlackRock Science Cash

2.95 Million

BlackRock Valuation Trend

Analysing the historical paterns of BlackRock Science's enterprise value and its market capitalization is a good way to estimate and gauge the value of BlackRock Science and over time and is usually enough for investors to make rational market timing decisions.

BlackRock Science Total Value Analysis

BlackRock Science and is currently anticipated to have valuation of 0 with market capitalization of 1.58 B, debt of 3.21 M, and cash on hands of . Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the BlackRock Science fundamentals before making equity appraisal based on enterprise value of the company

BlackRock Science Asset Utilization

The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of BlackRock suggests not a very effective usage of assets in December.
 
Covid

BlackRock Science Ownership Allocation

BlackRock Science holds a total of 74.17 Million outstanding shares. Almost 79.63 percent of BlackRock Science outstanding shares are held by general public with 20.37 % by other corporate entities. On May 24, 2020, Senator Thomas R Carper of US Senate acquired under $15k worth of BlackRock Science's common stock.

BlackRock Science Profitability Analysis

The company reported the previous year's revenue of 282.21 M. Net Income was 279.96 M with profit before overhead, payroll, taxes, and interest of 0.

BlackRock Science Past Distributions to stockholders

About BlackRock Science Valuation

Our relative valuation model uses a comparative analysis of BlackRock Science. We calculate exposure to BlackRock Science's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of BlackRock Science's related companies.
Last ReportedProjected for Next Year
Gross Profit282.2 M296.3 M
Pretax Profit Margin 1.00  0.95 
Operating Profit Margin 1.00  0.95 
Net Profit Margin 1.00  0.95 
Gross Profit Margin 0.15  0.14 

BlackRock Science Quarterly Retained Earnings

531.15 Million

BlackRock Science's stock price is the clearest measure of market expectations about its performance. Without stock valuation, investors cannot independently discern whether BlackRock Science's value is low or high relative to the company's performance and growth projections. Determining the market value of BlackRock Science can be done in different ways, such as multiplying its stock price by its outstanding shares.
A single share of BlackRock Science represents a small ownership stake in the entity. As a stockholder of BlackRock, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.

BlackRock Science Dividends Analysis For Valuation

Dividends Paid is likely to rise to about (135.7 M) in 2024. Dividend Yield is likely to drop to 0.06 in 2024. At this time, BlackRock Science's Retained Earnings are fairly stable compared to the past year. Earnings Yield is likely to rise to 0.27 in 2024, whereas Price Earnings To Growth Ratio is likely to drop (0.03) in 2024.
Last ReportedProjected for Next Year
Dividends Paid-142.8 M-135.7 M
Dividend Yield 0.09  0.06 
Dividend Payout Ratio 0.33  0.33 
Dividend Paid And Capex Coverage Ratio(0.36)(0.37)
There are various types of dividends BlackRock Science can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of BlackRock shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from BlackRock Science and directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When BlackRock pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of BlackRock Science by the value of the dividends paid out.

BlackRock Science Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
Common Stock Shares Outstanding76.1 M

BlackRock Science Current Valuation Indicators

Valuation refers to the process of determining the present value of BlackRock Science and and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value BlackRock we look at many different elements of the entity such as BlackRock's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as BlackRock Science, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use BlackRock Science's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes BlackRock Science's worth.

Additional Tools for BlackRock Stock Analysis

When running BlackRock Science's price analysis, check to measure BlackRock Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BlackRock Science is operating at the current time. Most of BlackRock Science's value examination focuses on studying past and present price action to predict the probability of BlackRock Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BlackRock Science's price. Additionally, you may evaluate how the addition of BlackRock Science to your portfolios can decrease your overall portfolio volatility.